These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25648389)

  • 1. Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus.
    Machado-Alba JE; Machado-Duque ME; Moreno-Gutierrez PA
    Diabetes Res Clin Pract; 2015 Mar; 107(3):332-7. PubMed ID: 25648389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.
    Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A
    Diabetes Res Clin Pract; 2020 Apr; 162():108090. PubMed ID: 32088311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
    Kuo S; Yang CT; Wu JS; Ou HT
    Diabetes Obes Metab; 2019 Feb; 21(2):312-320. PubMed ID: 30187666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes.
    Ringborg A; Lindgren P; Yin DD; Martinell M; Stålhammar J
    Diabetes Metab; 2010 Jun; 36(3):198-203. PubMed ID: 20347376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
    Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
    Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015.
    Lunger L; Melmer A; Oberaigner W; Leo M; Juchum M; Pölzl K; Gänzer J; Innerebner M; Eisendle E; Beck G; Kathrein H; Heindl B; Schönherr HR; Lechleitner M; Tilg H; Ebenbichler C
    Wien Klin Wochenschr; 2017 Jan; 129(1-2):46-51. PubMed ID: 27909794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006.
    Foster PD; Mamdani MM; Juurlink DN; Shah BR; Paterson JM; Gomes T
    Diabet Med; 2013 Oct; 30(10):1209-13. PubMed ID: 23586333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
    Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
    Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Obes Metab; 2012 Sep; 14(9):803-9. PubMed ID: 22486923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in metformin use and other antihyperglycemic therapies after insulin initiation in patients with type 2 diabetes.
    Pilla SJ; Dotimas JR; Maruthur NM; Clark JM; Yeh HC
    Diabetes Res Clin Pract; 2018 May; 139():221-229. PubMed ID: 29524481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy.
    Zaorsky NG; Shaikh T; Ruth K; Sharda P; Hayes SB; Sobczak ML; Hallman MA; Smaldone MC; Chen DY; Horwitz EM
    Clin Genitourin Cancer; 2017 Apr; 15(2):326-335.e3. PubMed ID: 27789181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care.
    Nefs G; Pop VJ; Denollet J; Pouwer F
    PLoS One; 2013; 8(11):e78865. PubMed ID: 24223860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
    Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
    Jil M; Rajnikant M; Richard D; Iskandar I
    Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
    Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
    Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.